Treg depletion potentiates checkpoint inhibition in claudin-low breast cancerNicholas Taylor, Jonathan S. Serody, Shannon Reisdorf et al.|Journal of Clinical Investigation|2017Cited by 143
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancerCarey K. Anders, Jonathan S. Serody, Mark G. Woodcock et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 28
Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast TumorsBenjamin G. Vincent, Jonathan S. Serody, Danielle M. File et al.|The Journal of Immunology|2023Cited by 19